Mary Garrett is Director of PROCEPT BioRobotics Corp. Currently has a direct ownership of 12,847 shares of PRCT, which is worth approximately $794,843. The most recent transaction as insider was on Jun 04, 2024, when has been sold 1,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K
12.0% 3M change
12.0% 12M change
Total Value Held $794,843

Mary Garrett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
BUY
Grant, award, or other acquisition
-
1,376 Added 9.67%
12,847 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
2,711 Added 19.12%
11,471 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
$74,997 $37.48 p/Share
2,001 Added 18.59%
8,760 Common Stock
Dec 29 2021
BUY
Grant, award, or other acquisition
$199,999 $29.59 p/Share
6,759 Added 50.0%
6,759 Common Stock

Also insider at

ETD
ETHAN ALLEN INTERIORS INC Consumer Cyclical
OMCL
OMNICELL, Inc Healthcare
MG

Mary Garrett

Director
Redwood City, CA

Track Institutional and Insider Activities on PRCT

Follow PROCEPT BioRobotics Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

News

Receive news related to PROCEPT BioRobotics Corp

Track Activities on PRCT